Clinical Trials Logo

Syndrome clinical trials

View clinical trials related to Syndrome.

Filter by:

NCT ID: NCT04224454 Completed - Clinical trials for Primary Sjögren Syndrome

Vaccine Coverage and Primary Sjögren'Syndrome

VACGREN
Start date: January 1, 2016
Phase:
Study type: Observational

Evaluation of vaccination coverage for influenza, pneumococcus and DTP in patients with pSS and investigated the reasons for non-vaccination.

NCT ID: NCT04224168 Recruiting - Clinical trials for Short Bowel Syndrome

Pectin Use in Pediatric Intestinal Rehabilitation

PUPI
Start date: January 1, 2020
Phase: N/A
Study type: Interventional

Pediatric short bowel patients, age 6 months to 21 years old, followed in our intestinal rehabilitation clinic, will be screened for qualification in the study. If meets qualification, will be consented for the study. The study involves patients receiving green beans in their diet for three months with data collection including stooling patterns as well as labs, and then switching over to liquid pectin for three months. Again data collection will take place. The duration of the study once patient is consented is ~6 months.

NCT ID: NCT04223986 Completed - Clinical trials for Acute Coronary Syndrome

Prehospital Risk Stratification in Acute Coronary Syndromes

Pre-ACS
Start date: November 30, 2017
Phase: N/A
Study type: Interventional

A feasibility study of prehospital echocardiographic examination and point-of-care troponin analysis, conducted by paramedics, in patients with suspected acute coronary syndrome. Echocardiographic images are sent together with information of TnT values and ECG signs to there cardiologist on call, deciding for immediate Cath lab (PCI) evaluation or local hospital evaluation.

NCT ID: NCT04223908 Completed - Clinical trials for Familial Chylomicronemia Syndrome

InFocus France Epidemiological Study of Health Burden in Major Hypertriglyceridemia

InFocus
Start date: September 19, 2018
Phase:
Study type: Observational

FCS and MCS patients recruited from 7 academic reference centers were invited to answer a paper or a web questionnaire. Questions encompassed demographics, physical, cognitive and mental symptoms, health care circuit, past and current disease management, satisfaction regarding healthcare providers and impact on daily life.

NCT ID: NCT04222608 Recruiting - Oncology Clinical Trials

The BRAvAdO Registry

BRAvAdO
Start date: September 1, 2016
Phase:
Study type: Observational [Patient Registry]

The BRAVADO Registry pretends to identify stratification, diagnosis, total atherosclerotic burden and treatment approaches in oncologic patients with Acute Coronary Syndrome (ACS) and identify strategies to improve health care quality

NCT ID: NCT04221737 Recruiting - Clinical trials for Acute Respiratory Distress Syndrome

Early Use of Airway Pressure Release Ventilation (APRV) in ARDS

Start date: July 15, 2017
Phase: N/A
Study type: Interventional

Airway pressure release ventilation (APRV) is a time-cycled, pressure controlled, intermittent mandatory ventilation mode with extreme inverse I:E ratios. Currently it is considered as a non-conventional ventilatory mode. The investigators aim to compare APRV with conventional mechanical ventilation (MV) in patients with acute respiratory distress syndrome (ARDS).

NCT ID: NCT04219280 Recruiting - ADHD Clinical Trials

Evaluating Treatment of ADHD in Children With Down Syndrome

TEAM-DS
Start date: October 2, 2020
Phase: Phase 4
Study type: Interventional

Children with Down syndrome (DS) have a 3-5 time greater prevalence of Attention Deficit Hyperactivity Disorder (ADHD) than typically developing (TD) children. Despite this higher risk of ADHD, rates of stimulant medication treatment are disproportionately low in children with DS+ADHD, even though stimulants are the most efficacious ADHD treatment and are recommended by consensus guidelines for use in children with intellectual disability and ADHD. The investigators propose the first randomized clinical trial (RCT) of stimulant medication in children with DS+ADHD. This RCT may provide evidence regarding the short- and long-term safety and efficacy of stimulant use in children with DS+ADHD, both with and without CHD. All children enrolled in the study will complete a comprehensive assessment battery evaluating ADHD diagnostic criteria, as well as behavioral, cognitive, academic, and functional impairments.

NCT ID: NCT04217733 Recruiting - Clinical trials for IBS - Irritable Bowel Syndrome

Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome

Start date: November 1, 2019
Phase: Phase 3
Study type: Interventional

Ethosuximide and pentoxifylline in the treatment of abdominal pain related to irritable bowel syndrome

NCT ID: NCT04216797 Withdrawn - Clinical trials for Levator Ani Syndrome

Rectal Versus Oral Diazepam Administration in the Treatment of Levator Ani Syndrome

Start date: January 9, 2020
Phase: Phase 4
Study type: Interventional

This research involves collecting data about levator ani syndrome (LAS) associated rectal pain and a comparison of diazepam treatment administration routes. The goal of this research is to see if an alternative route of diazepam administration provides sufficient control of LAS discomfort and low sleep quality while minimizing systemic effects of diazepam (drowsiness).

NCT ID: NCT04216485 Completed - Clinical trials for Overweight and Obesity

Lifestyle Intervention in Pregnant Women With PCOS

Start date: October 2016
Phase: N/A
Study type: Interventional

Polycystic ovarian syndrome (PCOS) is the most common reproductive disorder in women of childbearing age and is also associated with metabolic abnormalities including obesity, type 2 diabetes, dyslipidemia, etc. Importantly, a number of adverse outcome are seen in pregnancies complicated by PCOS, including gestational diabetes mellitus (GDM), preeclampsia and miscarriage. However, optimal management of PCOS complicated pregnancy is not known. This study seeks to explore whether healthy lifestyle intervention in overweight/obese pregnant women with PCOS could reduce gestational weight gain (GWG) and incidence of GDM.